According to Cyclerion Therapeutics 's latest financial reports the company's current EPS (TTM) is -$18.53. In 2022 the company made an earnings per share (EPS) of -$28.67 an increase over its 2021 EPS that were of -$38.12.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$17.66 | -38.42% |
2022 | -$28.67 | -24.78% |
2021 | -$38.12 | -47.86% |
2020 | -$73.11 | -42.89% |
2019 | -$128.01 | 6.61% |
2018 | -$120.07 |